Skip to main content
Rachid Baz, MD, Oncology, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

RachidCBazMD

Oncology • Tampa, FL

Hematologic Oncology

Physician

Request Appointment

Overview of Dr. Baz

Dr. Rachid Baz is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 17 years. Dr. Baz accepts several types of health insurance, listed below. He is one of 171 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He also speaks multiple languages, including Arabic and French. He has more than 100 publications and over 500 citings.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 2001 - 2004
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2008 - 2026
  • OH State Medical License
    OH State Medical License 2001 - 2009
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Twice‐Weekly Ixazomib in Combination with Lenalidomide‐Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma  
    Myo Htut, Michaela Liedtke, Stephen D Smith, Craig C Hofmeister, Rachid Baz, Paul G Richardson, Cara A Rosenbaum, David H Vesole, Ajai Chari, Jesus G Berdeja, Noopur Raje, British Journal of Haematology

Abstracts/Posters

  • The Result of a Phase 1 Study of Selinexor in Combination with High-Dose Melphalan and Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
    Rachid Baz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in ...
    Rachid Baz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Moffitt Cancer Center 2-Year Single-Institution Experience with Next-Generation Sequencing Minimal Residual Disease Detection: Clinical Utility, Application, and Corre...
    Rachid Baz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Novel Antibody Strategies in Relapsed/Refractory Myeloma 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA Approval
    Moffitt Research of Selinexor for Relapsed/Refractory Multiple Myeloma Facilitates Recent FDA ApprovalJuly 24th, 2019
  • Plethora of Novel Agents Transforming Outcomes in Multiple Myeloma
    Plethora of Novel Agents Transforming Outcomes in Multiple MyelomaJuly 28th, 2017
  • Phase 1 Study Results of Selinexor Combination Therapy; Multiple Myeloma
    Phase 1 Study Results of Selinexor Combination Therapy; Multiple MyelomaJune 6th, 2016
  • Join now to see all

Professional Memberships

Other Languages

  • Arabic, French

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Dr. Rachid Baz, Dr. Rachid Baz, MD, Dr. R Baz, Dr. Rachid C Baz